Skip to main content

WATSON 836 7.5 Pill - beige five-sided

Pill with imprint WATSON 836 7.5 is Beige, Five-sided and has been identified as Clorazepate Dipotassium 7.5 mg. It is supplied by Watson Laboratories, Inc.

Clorazepate is used in the treatment of Anxiety; Seizure Prevention; Alcohol Withdrawal; Epilepsy; Seizures and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Clorazepate 7.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 836 7.5

Clorazepate dipotassium 7.5 mg WATSON 836 7.5 Front
Clorazepate dipotassium 7.5 mg WATSON 836 7.5 Back
Clorazepate dipotassium 7.5 mg WATSON 836 7.5

Clorazepate Dipotassium

Imprint
WATSON 836 7.5
Strength
7.5 mg
Color
Beige
Shape
Five-sided
Availability
Prescription only
Drug Class
Benzodiazepines
Pregnancy Category
N - Not classified
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
52544-0836 (Discontinued)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.